No abstract available
Keywords:
antidepressants; endotype; musculoskeletal pain; myofascial unit; personalised medicine; phenotype; sex hormone deficiency; theratype.
Grants and funding
The authors declare financial support was received for the research, authorship, and/or publication of this article. MRR is funded by the National Institute for Health and Social Care (NIHR) Manchester Biomedical Research Centre (NIHR203308). The views expressed are those of the author and not necessarily those of the NIHR or the Department of Health and Social Care. LC is funded by the International Postdoctoral Exchange Fellowship Program (Talent-Introduction Program, YJ20220294) and the China Postdoctoral Science Foundation under Grant Number 2024M751834.